FDG PET-CT in follicular lymphoma: a case-based evidence review. - Wikidata - wikimedia - TriplyDB

FDG PET-CT in follicular lymphoma: a case-based evidence review.

FDG PET-CT in follicular lymphoma: a case-based evidence review.

http://www.wikidata.org/entity/Q35080079

about

Radiotherapy for Non-Hodgkin's lymphoma: still standard practice and not an outdated treatment option PET-CT in Staging, Response Evaluation, and Surveillance of Lymphoma.Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy.18F-Fluorodeoxyglucose positron emission tomography computed tomography detection threshold in follicular lymphoma: A case report.Whole body magnetic resonance in indolent lymphomas under watchful waiting: The time is now.FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study.Application of Quantitative Indexes of FDG PET to Treatment Response Evaluation in Indolent Lymphoma

P2860

Q28079951-C6024686-6C53-4FE7-8ECE-9AA1C66C2852 Q38794783-B6906797-C923-4847-B2EE-5F78502A7244 Q41008736-EBA34ABF-7EB1-4858-9C27-051E679893D1 Q47143879-01636728-BC08-45D5-BDE5-2F3F01F53AA1 Q48212826-B2A76264-0C99-499E-89B1-927C97DF28EE Q52982144-3FE8C500-F242-49A1-953B-FEE99DF07C65 Q57820488-383C6936-DB1E-4722-980D-108C8CF77695

P2860

FDG PET-CT in follicular lymphoma: a case-based evidence review.

http://www.wikidata.org/entity/Q35080079

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

FDG PET-CT in follicular lymphoma: a case-based evidence review.

@ast

FDG PET-CT in follicular lymphoma: a case-based evidence review.

@en

type

label

FDG PET-CT in follicular lymphoma: a case-based evidence review.

@ast

FDG PET-CT in follicular lymphoma: a case-based evidence review.

@en

prefLabel

FDG PET-CT in follicular lymphoma: a case-based evidence review.

@ast

FDG PET-CT in follicular lymphoma: a case-based evidence review.

@en

P1433

Q35080079-B7EBA5FB-0C57-4636-90F6-0FA6DD7BB01A

P1476

Q35080079-EC30269F-FE8D-4CA5-8CE1-AF60CC1FEDDA

P2093

Q35080079-1D7B780C-B3A2-4B58-9019-9D2646112322

Q35080079-38E8FF1D-1EBF-469B-9628-4B972209BC01

Q35080079-51965D7A-1207-4C7E-9158-FD212422B4D9

P2860

Q35080079-020D492F-16EB-4643-88B3-84F9087E2D19

Q35080079-047E79E4-A348-4320-8A62-BD350F7BDCA4

Q35080079-06DEF7E1-089F-4701-B550-546213073FA3

Q35080079-0D6F0A5D-40AD-44DF-BB1D-4DAF1C4EBFFD

Q35080079-2A2A6E33-9663-4D48-AB90-0D3775232050

Q35080079-2CA970A6-9036-4BE5-926B-510578942C7F

Q35080079-2EB55EEE-6033-4F5E-BB1D-125DC8C82522

Q35080079-3515021B-70DE-47A7-BAAD-462146EA7903

Q35080079-3A2D3A24-99DE-4007-9AA2-362104F76A52

Q35080079-3EBC9C7D-EDE7-473A-A46A-42927B7688AE

P304

Q35080079-42F2BCC6-DEDC-49E3-B519-88B4C5CB8A9D

P31

Q35080079-1332FE5A-082D-44E7-B7FF-4FE9CAB5B19F

P356

Q35080079-7B134776-1A2D-4851-8529-FAA85541F787

P407

Q35080079-65731B29-FC37-4011-B4D1-F508B6DEA037

P433

Q35080079-E8A632BB-6011-4E55-8744-32E4CDCF8D4A

P478

Q35080079-36D22E9B-F9E1-44E3-B850-901FC56ECA74

P577

Q35080079-7F119E4F-60FD-4483-A8A9-FE58CE700705

P5875

Q35080079-30D22409-5D27-48E0-90CF-7B3AD96FC7BB

P698

Q35080079-EBE4AB49-5FA4-4995-B7B4-0F79039A7940

P932

Q35080079-144A4F55-3A72-410E-A985-8B29A4FCCED7

P356

BLOOD-2014-11-537522

P1433

P1476

FDG PET-CT in follicular lymphoma: a case-based evidence review.

@en

P2093

Kieron Dunleavy

http://www.w3.org/2001/XMLSchema#string

Mary Redman

http://www.w3.org/2001/XMLSchema#string

Stephen D Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010

High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults

Grading quality of evidence and strength of recommendations

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.

Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis.

Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study.

P304

1078-1082

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2014-11-537522

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269876829

http://www.w3.org/2001/XMLSchema#string

P698

25527711

http://www.w3.org/2001/XMLSchema#string

P932

4326769

http://www.w3.org/2001/XMLSchema#string